Welcome to the Fierce Biotech Graveyard, a yearly ritual where we remember all the biotechs we lost in 2025. While we're ...

Now, it’s worth noting Stock Advisor's total average return is 1,072% — a market-crushing outperformance compared to 194% for the S&P 500. Don’t miss out on the latest top 10 list, available when you ...

A report by GlobalData revealed that the biotech industry witnessed a 70.9% increase in total venture financing deal value.

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce ...

The company's technology has been called "essential for the future of biomanufacturing." ...

Ipsen is set to purchase all issued and outstanding shares of the French biotech company ImCheck Therapeutics.

In this interview, Charles Chase, PhD, the VP and Technical Business Development at Asymchem, a technology-focused pharmaceutical manufacturing company, discusses the significant impact of RNA ...

The U.S. inked Technology Prosperity Deals (TPD) with Japan and South Korea with an eye toward spurring collaboration on AI, ...

Showcase your company news with guaranteed exposure both in print and online Most Admired CEOs were built for times like these. Their leadership & actions are guiding the… Discover how AI and emerging ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

The latest announcement is out from Aqua Bio Technology ASA ( ($DE:3FZ) ). Aqua Bio Technology ASA is set to release a quarterly financial report ...